Harmony Biosciences Holdings HRMY
NASDAQ HRMY
$39.26 -0.03 (-0.08%)
At close: Sep 30, 2026 · 4:00 PM EDT

Harmony Biosciences Holdings (HRMY) Total Non-Current Liabilities (2019 - 2026)

Updated

Harmony Biosciences Holdings' Total Non-Current Liabilities came in at $139.77 million for Q2 2026, down 9.7% from $154.79 million a year earlier and down 3.0% from the prior quarter.

Analysis

Harmony Biosciences Holdings (HRMY) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends

At the end of FY2025, Harmony Biosciences Holdings' Total Non-Current Liabilities was $149.28 million, down 9.5% from FY2024.

  • Total Non-Current Liabilities has declined in each of the last five years, with a five-year compound annual growth rate of -5.2% (FY2020 to FY2025).
  • Going back by year, Total Non-Current Liabilities was $164.96 million in FY2024 (-8.7%), $180.68 million in FY2023 (-6.0%), $192.15 million in FY2022 (-0.5%) and $193.16 million in FY2021 (-1.1%).
  • The Q2 2026 figure represents the lowest quarterly Total Non-Current Liabilities since Q4 2019.
  • Year-over-year, Total Non-Current Liabilities has declined for 15 consecutive quarters, with an average decline of 9.7% over the last eight quarters.
  • The fastest year-over-year change in Total Non-Current Liabilities over five years came in Q3 2022 (growth of 0.4%), and the weakest in Q3 2025 (a decline of 12.0%).
  • Business Quant data shows HRMY's Total Non-Current Liabilities at $144.14 million (Q1 2026), $149.28 million (Q4 2025) and $149.69 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 105.99 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 106.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -967.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 36.04 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.92 Bn
10 Harmony Biosciences Holdings 2.28 Bn -474.81 Mn 198.08 Mn 139.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 139.77 Mn
Mar 31, 2026 144.14 Mn
Dec 31, 2025 149.28 Mn
Sep 30, 2025 149.69 Mn
Jun 30, 2025 154.79 Mn
Mar 31, 2025 159.89 Mn
Dec 31, 2024 164.96 Mn
Sep 30, 2024 170.05 Mn
Jun 30, 2024 173.22 Mn
Mar 31, 2024 177.34 Mn
Dec 31, 2023 180.68 Mn
Sep 30, 2023 184.03 Mn
Jun 30, 2023 181.97 Mn
Mar 31, 2023 186.69 Mn
Dec 31, 2022 192.15 Mn
Sep 30, 2022 192.22 Mn
Jun 30, 2022 192.74 Mn
Mar 31, 2022 192.97 Mn
Dec 31, 2021 193.16 Mn
Sep 30, 2021 191.45 Mn
API Access

Harmony Biosciences Holdings Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=HRMY&period=max&api_key=YOUR_API_KEY